Dr. Reddy's and Pharmazz inks agreement to market Centhaquine for hypovolemic shock in India
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Pharma Solutions operates 10 research and development and/or production sites globally
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Additional capacity broadens Grace’s fine chemical capabilities for API production
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Subscribe To Our Newsletter & Stay Updated